QQQ   431.64 (+0.13%)
AAPL   169.12 (-2.07%)
MSFT   415.95 (+0.56%)
META   501.82 (+0.32%)
GOOGL   154.52 (-0.22%)
AMZN   183.55 (-0.04%)
TSLA   157.43 (-2.51%)
NVDA   873.80 (+1.60%)
AMD   163.55 (+2.01%)
NIO   3.82 (-1.80%)
BABA   69.99 (-0.89%)
T   16.04 (-1.23%)
F   12.17 (-0.49%)
MU   121.26 (-0.09%)
GE   155.42 (+1.12%)
CGC   6.86 (-1.72%)
DIS   113.97 (+0.90%)
AMC   2.74 (+10.93%)
PFE   25.83 (-0.31%)
PYPL   63.85 (+0.54%)
XOM   118.51 (-0.98%)
QQQ   431.64 (+0.13%)
AAPL   169.12 (-2.07%)
MSFT   415.95 (+0.56%)
META   501.82 (+0.32%)
GOOGL   154.52 (-0.22%)
AMZN   183.55 (-0.04%)
TSLA   157.43 (-2.51%)
NVDA   873.80 (+1.60%)
AMD   163.55 (+2.01%)
NIO   3.82 (-1.80%)
BABA   69.99 (-0.89%)
T   16.04 (-1.23%)
F   12.17 (-0.49%)
MU   121.26 (-0.09%)
GE   155.42 (+1.12%)
CGC   6.86 (-1.72%)
DIS   113.97 (+0.90%)
AMC   2.74 (+10.93%)
PFE   25.83 (-0.31%)
PYPL   63.85 (+0.54%)
XOM   118.51 (-0.98%)
QQQ   431.64 (+0.13%)
AAPL   169.12 (-2.07%)
MSFT   415.95 (+0.56%)
META   501.82 (+0.32%)
GOOGL   154.52 (-0.22%)
AMZN   183.55 (-0.04%)
TSLA   157.43 (-2.51%)
NVDA   873.80 (+1.60%)
AMD   163.55 (+2.01%)
NIO   3.82 (-1.80%)
BABA   69.99 (-0.89%)
T   16.04 (-1.23%)
F   12.17 (-0.49%)
MU   121.26 (-0.09%)
GE   155.42 (+1.12%)
CGC   6.86 (-1.72%)
DIS   113.97 (+0.90%)
AMC   2.74 (+10.93%)
PFE   25.83 (-0.31%)
PYPL   63.85 (+0.54%)
XOM   118.51 (-0.98%)
QQQ   431.64 (+0.13%)
AAPL   169.12 (-2.07%)
MSFT   415.95 (+0.56%)
META   501.82 (+0.32%)
GOOGL   154.52 (-0.22%)
AMZN   183.55 (-0.04%)
TSLA   157.43 (-2.51%)
NVDA   873.80 (+1.60%)
AMD   163.55 (+2.01%)
NIO   3.82 (-1.80%)
BABA   69.99 (-0.89%)
T   16.04 (-1.23%)
F   12.17 (-0.49%)
MU   121.26 (-0.09%)
GE   155.42 (+1.12%)
CGC   6.86 (-1.72%)
DIS   113.97 (+0.90%)
AMC   2.74 (+10.93%)
PFE   25.83 (-0.31%)
PYPL   63.85 (+0.54%)
XOM   118.51 (-0.98%)
NASDAQ:DRTX

(DRTX) (DRTX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
DRTX stock logo

About (DRTX) Stock (NASDAQ:DRTX)

Durata Therapeutics, Inc. is a pharmaceutical company focused on the development and commercialization of therapeutics for patients with infectious diseases and acute illnesses. The Company enroll and dose patients in two global Phase III clinical trials with its product candidate, dalbavancin, for the treatment of patients with acute bacterial skin and skin structure infections (abSSSI). Dalbavancin is an intravenous antibiotic product candidate designed for once-weekly dosing. In addition to abSSSI, the Company focuses on the development of dalbavancin for additional indications, including osteomyelitis, diabetic foot infection and pneumonia. As of December 31, 2011, Dalbavancin had already completed three Phase III clinical trials, in which more than 1,000 patients in total received dalbavancin.

DRTX Stock News Headlines

FSLR Crosses Above Key Moving Average Level
The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
UFC 287 Loses Bout In Final Hour
Campus notes
See More Headlines
Receive DRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (DRTX) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:DRTX
CUSIP
26658A10
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

DRTX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (DRTX) own?
This page (NASDAQ:DRTX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners